Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis—the PMEP trial: study protocol for a randomized controlled trial
Mark T. Jennings(Johns Hopkins University), Elliott C. Dasenbrook(Cleveland Clinic), Michael Boyle(McMaster University), Karen Callahan(Johns Hopkins University), David Weaver(University Hospitals Cleveland Medical Center)
Cited by 28
Related Papers
Update on Key Emerging Challenges in Cystic Fibrosis
|Medical Principles and Practice|2014|3.7k
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System
|Medical Care|2002|1.3k
Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis
|Science|1990|979
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939